Form 4: Ceribell Inc. Executive Receives Stock Grant
Statement of Changes in Beneficial Ownership
Joseph S. Manni, Chief Revenue Officer at Ceribell, Inc., was granted restricted stock units and acquired stock options on April 1, 2026.
Summary
- Joseph S. Manni, Chief Revenue Officer of Ceribell, Inc., received a grant of 30,736 restricted stock units (RSUs) on April 1, 2026.
- Additionally, Manni acquired 51,227 stock options with an exercise price of $18.50, exercisable on April 1, 2036.
- The RSUs were acquired at no cost.
- The stock options are subject to vesting on each quarterly anniversary from May 20, 2026, contingent upon continued employment.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine executive compensation and does not contain new financial performance data or strategic shifts.
Positives
- Grant of restricted stock units indicates a form of equity-based compensation, potentially aligning executive interests with shareholder value.
- Acquisition of stock options provides an incentive for future stock price appreciation.
- The vesting schedule for stock options encourages long-term commitment from the executive.
Negatives
- The filing does not provide details on the valuation of the RSUs or the potential future value of the stock options.
- No information is provided regarding the performance conditions, if any, associated with the RSU grant.
Risks
- The value of the stock options is entirely dependent on the future performance and stock price of Ceribell, Inc.
- If the executive's employment is terminated, unvested options and RSUs may be forfeited.
- The exercise price of the stock options ($18.50) implies a significant increase in share price is needed for them to be profitable.
Future Outlook
The vesting schedule for the stock options suggests a long-term outlook for the executive's role and the company's potential growth, with options exercisable up to April 1, 2036.
Industry Context
StockSavvy.ai notes that grants of RSUs and stock options are standard practice in the technology and healthcare sectors for executive compensation, aimed at retaining talent and incentivizing performance tied to stock appreciation.
Stakeholder Impact
- Shareholders: The grant of equity awards to executives is a common practice that can align management's interests with those of shareholders, potentially driving long-term value creation.
- Employees: The executive's compensation structure may influence overall employee morale and retention strategies within the company.
- Management: The awards provide financial incentives for the Chief Revenue Officer to perform and contribute to the company's success.
Next Steps
- Vesting of stock options on a quarterly basis starting May 20, 2026, subject to continued employment.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Transaction Date for RSU grant and stock option acquisition. |
| 05/20/2026 | Start date for the quarterly vesting of stock options. |
| 04/01/2036 | Expiration date for the acquired stock options. |
| 04/03/2026 | Date the Form 4 was signed. |
Keywords
Form 4, SEC Filing, Ceribell Inc., CBLL, Joseph S. Manni, Restricted Stock Units, RSUs, Stock Options, Executive Compensation, Insider Trading, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.